Ostatní
Návod 
Bristol-Myers Squibb Company
BMY
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
95.5B
Obrat
48B
Zisk
7B
Aktiva
97B
Dluh
51B
ROE
0%
ROA
0%
PE
17
PS
2
Cena 1R
43-63
⌀ Cena
48.31
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
23-04-2026
Poslední dividenda
02-01-2026
Profil
Společnost Bristol-Myers Squibb Company objevuje, vyvíjí, licencuje, vyrábí a prodává biofarmaceutické výrobky po celém světě. Nabízí produkty pro hematologii, onkologii, kardiovaskulární, imunologii, fibrotická, neurovědecká a covid-19 onemocnění. Mezi produkty společnosti patří Revlimid, perorální imunomodulační přípravek pro léčbu mnohočetného myelomu; Eliquis, perorální inhibitor pro snížení rizika mrtvice/systémové embolie v NVAF a pro léčbu DVT/PE; Opdivo pro protinádorové indikace; Pomalyst/Imnovid indikovaný u pacientů s mnohočetným myelomem; a Orencia pro dospělé pacienty s aktivní RA a psoriatickou artritidou. Dále poskytuje přípravek Sprycel pro léčbu chronické myeloidní leukémie s pozitivním Philadelphia chromosomem; Yervoy pro léčbu pacientů s neresekovatelným nebo metastazujícím melanomem; Abraxane, chemoterapeutický přípravek vázaný na bílkoviny; Reblozyl pro léčbu anémie u dospělých pacientů s beta-talasemií; a Empliciti pro léčbu mnohočetného myelomu. Společnost dále nabízí Zeposii k léčbě relabujících forem roztroušené sklerózy; Breyanzi, geneticky modifikovanou autologní T-buněčnou imunoterapii řízenou CD19 k léčbě dospělých pacientů s relabujícím nebo refrakterním velkým B-buněčným lymfomem; Inrebic, inhibitor perorální kinázy, který je indikován k léčbě dospělých pacientů s myelofibrózou; a Onureg k léčbě dospělých pacientů s AML. Prodává výrobky velkoobchodníkům, distributorům, lékárnám, maloobchodům, nemocnicím, klinikám a vládním agenturám. Společnost byla dříve známá jako Bristol-Myers Company. Společnost byla založena v roce 1887 a sídlí v New Yorku.
Sektor
Healthcare
Odvětví
Drug Manufacturers - General
Počet zaměstnanců
34100
Založení
1972-06-01
Podobné společnosti
$ 46.75
+ $ 0.12
$ 455.55
- $ 21.06
$ 50.17
+ $ 0.51
$ 260.66
- $ 3.93
$ 305.00
- $ 12.78
$ 77.62
- $ 1.37
$ 848.98
- $ 3.01
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Total Revenues | 48.19 | 48.19 | 48.30 | 45.01 | 46.16 | |
| Cost of Revenues | 15.59 | 15.59 | 20.87 | 10.69 | 10.14 | |
| Gross Profit | 32.60 | 32.60 | 27.43 | 34.31 | 36.02 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 12.50 | 12.22 | 12.27 | 11.20 | 12.34 | 11.89 | 12.20 | 11.87 | 11.48 | 10.97 | |
| Cost of Revenues | 4.10 | 3.44 | 4.20 | 3.86 | 4.92 | 5.28 | 5.40 | 5.28 | 2.75 | 2.51 | |
| Gross Profit | 8.41 | 8.79 | 8.07 | 7.34 | 7.42 | 6.62 | 6.80 | 6.59 | 8.73 | 8.46 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 9.30 | 9.51 | |
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 7.77 | 7.81 | |
| Depreciation & Amortization | 3.86 | 3.86 | 9.60 | 9.81 | 9.60 | |
| Total Operating Expenses | 19.91 | 19.91 | 17.77 | 34.31 | 26.92 | |
| Operating Income | 12.70 | 12.70 | 9.66 | 17.24 | 10.33 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.48 | 2.24 | ||
| Selling General & Admin Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.07 | 2.00 | ||
| Depreciation & Amortization | 0.83 | 0.99 | 1.03 | 1.01 | 1.88 | 2.59 | 2.60 | 2.53 | 2.46 | 2.45 | ||
| Total Operating Expenses | 6.99 | 5.15 | 3.95 | 3.82 | 4.89 | 4.33 | 4.22 | 5.06 | 6.83 | 4.25 | ||
| Operating Income | 1.42 | 3.64 | 4.12 | 3.52 | 2.53 | 2.29 | 2.58 | 1.54 | 1.68 | 4.22 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Interest Income | 0.30 | 0.30 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 1.51 | 1.51 | 1.95 | 1.17 | 1.23 | |
| Other Expense | -3.37 | -3.37 | -18.04 | -8.80 | -2.62 | |
| IBT | 9.33 | 9.33 | -8.38 | 8.44 | 7.71 | |
| Income Tax Expense | 2.27 | 2.27 | 0.55 | 0.40 | 1.37 | |
| Net Income | 7.05 | 7.05 | -8.95 | 8.03 | 6.33 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.00 | 0.16 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.11 | ||
| Interest Expense | 0.05 | 0.48 | 0.49 | 0.49 | 0.50 | 0.51 | 0.52 | 0.43 | 0.32 | 0.28 | ||
| Other Expense | 0.05 | -0.53 | -2.34 | -0.55 | -2.36 | -0.61 | -1.30 | -13.05 | -1.95 | -2.08 | ||
| IBT | 1.47 | 3.11 | 1.77 | 2.97 | 0.18 | 1.68 | 1.29 | -11.52 | 1.67 | 2.14 | ||
| Income Tax Expense | 0.38 | 0.92 | 0.46 | 0.51 | 0.10 | 0.46 | -0.40 | 0.39 | -0.09 | 0.20 | ||
| Net Income | 1.09 | 2.20 | 1.31 | 2.46 | 0.07 | 1.21 | 1.68 | -11.91 | 1.76 | 1.93 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $3.88 | $2.97 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $3.86 | $2.95 | |
| Shares Outstanding | 2.04 | 2.04 | 2.03 | 2.07 | 2.15 | |
| Diluted Shares Outstanding | 2.04 | 2.04 | 2.03 | 2.08 | 2.25 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.87 | $0.94 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.87 | $0.93 | ||
| Shares Outstanding | 2.04 | 2.04 | 2.04 | 2.03 | 2.03 | 2.03 | 2.03 | 2.02 | 2.03 | 2.06 | ||
| Diluted Shares Outstanding | 2.04 | 2.04 | 2.04 | 2.04 | 2.04 | 2.03 | 2.03 | 2.02 | 2.03 | 2.06 |
| Current Assets | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Cash And Equivalents | 6.30 | 10.35 | 11.46 | 9.12 | |
| Short Term Investments | 0.36 | 0.51 | 0.82 | 0.13 | |
| Total Cash & ST Investments | 6.66 | 10.86 | 12.28 | 9.12 | |
| Accounts Receivable | 15.15 | 14.42 | 15.26 | 13.94 | |
| Inventory | 3.08 | 2.56 | 2.66 | 2.34 | |
| Other Current Assets | 2.01 | 1.94 | 1.56 | 1.60 | |
| Total Current Assets | 26.89 | 29.78 | 31.77 | 27.27 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 15.73 | 12.60 | 10.88 | 10.35 | 7.89 | 6.29 | 9.33 | 11.46 | 7.51 | 8.37 | |
| Short Term Investments | 0.78 | 1.00 | 0.91 | 0.51 | 0.20 | 0.36 | 0.34 | 0.82 | 0.17 | 0.36 | |
| Total Cash & ST Investments | 16.50 | 13.60 | 11.78 | 10.86 | 8.09 | 6.65 | 9.67 | 12.28 | 7.69 | 8.37 | |
| Accounts Receivable | 14.62 | 15.10 | 14.59 | 14.42 | 14.90 | 15.15 | 14.06 | 15.26 | 15.65 | 15.06 | |
| Inventory | 2.76 | 2.74 | 2.67 | 2.56 | 3.33 | 3.08 | 2.99 | 2.66 | 2.44 | 2.36 | |
| Other Current Assets | 1.75 | 1.78 | 1.75 | 1.94 | 1.75 | 2.01 | 1.95 | 1.56 | 1.86 | 1.92 | |
| Total Current Assets | 35.63 | 33.22 | 30.78 | 29.78 | 28.08 | 26.89 | 28.67 | 31.77 | 27.63 | 28.07 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 8.16 | 8.36 | 8.04 | 7.48 | |
| Goodwill | 21.73 | 21.72 | 21.17 | 21.15 | |
| Intangible Assets | 29.84 | 23.64 | 27.07 | 36.36 | |
| Long-Term Investments | 3.00 | 2.51 | 2.50 | 2.19 | |
| Other Long-Term Assets | 1.70 | 2.36 | 1.85 | 1.04 | |
| Total Long-Term Assets | 67.76 | 62.82 | 63.39 | 69.55 | |
| Total Assets | 94.65 | 92.60 | 95.16 | 96.82 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 7.35 | 8.65 | 8.43 | 8.36 | 8.25 | 8.16 | 8.19 | 8.04 | 7.85 | 7.63 | |
| Goodwill | 21.75 | 21.78 | 21.74 | 21.72 | 21.75 | 21.73 | 21.74 | 21.17 | 21.15 | 21.16 | |
| Intangible Assets | 20.47 | 21.66 | 22.80 | 23.64 | 27.33 | 29.84 | 33.17 | 27.49 | 29.38 | 31.77 | |
| Long-Term Investments | 2.36 | 2.25 | 2.25 | 2.51 | 2.85 | 3.00 | 2.89 | 2.06 | 1.88 | 1.99 | |
| Other Long-Term Assets | 4.38 | 2.47 | 2.43 | 2.36 | 1.80 | 1.70 | 1.66 | 1.87 | 1.86 | 1.29 | |
| Total Long-Term Assets | 61.26 | 61.46 | 61.64 | 62.82 | 65.60 | 67.76 | 70.36 | 63.39 | 63.63 | 65.42 | |
| Total Assets | 96.89 | 94.68 | 92.43 | 92.60 | 93.67 | 94.65 | 99.03 | 95.16 | 91.26 | 93.49 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Accounts Payable | 3.75 | 3.60 | 3.26 | 3.04 | |
| Short-Term Debt | 3.71 | 2.23 | 3.28 | 4.40 | |
| Other Current Liabilities | 13.12 | 16.43 | 14.35 | 13.11 | |
| Current Liabilities | 23.27 | 23.77 | 22.26 | 21.89 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.29 | 5.43 | 4.00 | 3.60 | 3.47 | 3.75 | 3.54 | 3.26 | 2.81 | 3.07 | |
| Short-Term Debt | 4.72 | 4.91 | 3.73 | 2.23 | 1.24 | 3.71 | 6.36 | 3.28 | 5.62 | 3.19 | |
| Other Current Liabilities | 19.13 | 17.19 | 14.89 | 16.43 | 16.44 | 14.33 | 14.44 | 14.35 | 13.57 | 12.37 | |
| Current Liabilities | 28.14 | 27.53 | 24.07 | 23.77 | 22.64 | 23.27 | 25.82 | 22.26 | 23.46 | 20.15 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Long-Term Debt | 48.86 | 48.97 | 38.18 | 36.32 | |
| Capital Leases | 1.44 | 1.55 | 1.69 | 1.40 | |
| Def. Tax Liability | 0.46 | 0.37 | 0.34 | 2.17 | |
| Total Liabilities | 77.58 | 76.22 | 65.67 | 65.70 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 46.32 | 46.02 | 47.51 | 48.97 | 50.16 | 50.30 | 51.05 | 38.18 | 33.65 | 36.00 | |
| Capital Leases | 0.00 | 1.74 | 1.53 | 1.55 | 1.65 | 1.44 | 1.73 | 1.69 | 1.66 | 1.51 | |
| Def. Tax Liability | 0.23 | 0.25 | 0.28 | 0.37 | 0.43 | 0.46 | 0.44 | 0.34 | 0.40 | 0.75 | |
| Total Liabilities | 78.29 | 77.19 | 74.98 | 76.22 | 76.47 | 77.58 | 82.48 | 65.67 | 62.20 | 61.46 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Common Stock | 0.29 | 0.29 | 0.29 | 0.29 | |
| Retained Earnings | 16.10 | 14.91 | 28.77 | 25.50 | |
| Comprehensive Income | -1.46 | -1.24 | -1.55 | -1.28 | |
| Total Common Equity | 17.02 | 16.34 | 29.43 | 31.06 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | |
| Retained Earnings | 17.09 | 16.15 | 16.11 | 14.91 | 16.10 | 16.10 | 15.64 | 28.77 | 28.22 | 27.45 | |
| Comprehensive Income | -1.51 | -1.55 | -1.42 | -1.24 | -1.47 | -1.46 | -1.40 | -1.55 | -1.29 | -1.39 | |
| Total Common Equity | 18.55 | 17.44 | 17.39 | 16.34 | 17.14 | 17.02 | 16.49 | 29.43 | 29.00 | 31.97 |
| Other | TTM | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Total Debt | 54.00 | 51.20 | 41.46 | 40.72 | |
| Book Value | 17.07 | 16.39 | 29.49 | 31.12 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.05 | 0.05 | 0.06 | 0.05 | 0.06 | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Book Value | 18.55 | 17.44 | 17.39 | 16.34 | 17.14 | 17.02 | 16.49 | 29.43 | 29.00 | 31.97 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Net Income | -6.53 | 7.06 | -8.93 | 8.04 | 6.35 | |
| Depreciation & Amortization | 9.99 | 4.01 | 9.60 | 9.76 | 10.28 | |
| Stock-Based Compensation | 0.52 | 0.55 | 0.51 | 0.52 | 0.46 | |
| Change Working Capital | -1.03 | -0.46 | 0.81 | -1.91 | -2.23 | |
| Change In Accounts Receivable | -0.66 | -0.30 | 0.26 | -1.00 | -0.66 | |
| Change In Accounts Payable | 0.22 | 0.00 | 0.18 | 0.20 | 0.11 | |
| Change In Inventories | -0.90 | -0.18 | -0.49 | -0.75 | -0.07 | |
| Other Non-cash Items | 21.04 | 3.96 | 15.30 | 0.74 | 0.96 | |
| Cash from Operations | 14.16 | 0.00 | 0.00 | 13.86 | 13.07 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.09 | 2.20 | 1.31 | 2.46 | 0.08 | 1.22 | 1.68 | -11.91 | 1.76 | 1.93 | |
| Depreciation & Amortization | 0.98 | 1.01 | 1.01 | 1.01 | 1.88 | 2.59 | 2.60 | 2.53 | 2.46 | 2.44 | |
| Stock-Based Compensation | 0.13 | 0.14 | 0.14 | 0.14 | 0.12 | 0.13 | 0.13 | 0.13 | 0.13 | 0.13 | |
| Change Working Capital | -1.65 | 3.06 | 0.02 | -1.87 | 1.28 | 1.71 | -2.37 | 0.20 | 0.86 | 0.29 | |
| Change In Accounts Receivable | 0.02 | 0.16 | -0.48 | 0.02 | 0.14 | 0.66 | -1.02 | 0.48 | 0.54 | -0.66 | |
| Change In Accounts Payable | -0.09 | 0.16 | 0.01 | -0.09 | 0.52 | -0.37 | -0.26 | 0.30 | 0.44 | -0.27 | |
| Change In Inventories | 0.07 | -0.09 | 0.00 | -0.17 | 0.18 | -0.22 | -0.23 | -0.22 | -0.20 | -0.26 | |
| Other Non-cash Items | 1.83 | 0.27 | 1.88 | -0.02 | 1.88 | 0.20 | 0.62 | 12.59 | 0.37 | 0.29 | |
| Cash from Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.25 | 4.75 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Capital Expenditure | -1.22 | -1.31 | -1.25 | -1.21 | -1.12 | |
| Acquisitions | -21.33 | -2.87 | -20.72 | -0.26 | -2.98 | |
| Investments | -1.58 | -2.00 | -0.77 | -1.77 | -3.59 | |
| Sales of Investment | 1.44 | 2.05 | 1.39 | 0.95 | 6.63 | |
| Other Investing Activities | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash from Investing | -22.69 | 0.00 | 0.00 | -2.30 | -1.06 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.37 | -0.32 | -0.36 | -0.26 | -0.38 | -0.32 | -0.26 | -0.28 | -0.33 | -0.34 | |
| Acquisitions | -1.43 | -2.39 | -0.02 | 0.17 | 0.29 | -0.09 | -1.10 | -19.81 | -0.34 | -0.08 | |
| Investments | -0.08 | -0.67 | -0.62 | -0.64 | -0.37 | -0.04 | -0.08 | -0.27 | -0.72 | -0.50 | |
| Sales of Investment | 0.42 | 0.88 | 0.52 | 0.23 | 0.27 | 0.24 | 0.13 | 0.75 | 0.04 | 0.51 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.44 | 0.26 | |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.35 | -0.41 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Debt Repaid | -20.87 | 0.00 | 0.00 | 0.46 | -11.43 | |
| Debt Issued | 35.68 | 51.20 | 9.74 | 1.20 | 52.15 | |
| Issuance of Common Stock | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Repurchase of Common Stock | -4.00 | 0.00 | 0.00 | -5.16 | -8.00 | |
| Dividends Paid | -4.78 | 0.00 | 0.00 | -4.74 | -4.63 | |
| Other Financing Activities | 15.92 | 0.00 | 0.00 | 0.03 | 7.10 | |
| Cash from Financing | 6.43 | 0.00 | 0.00 | -9.42 | -16.96 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.10 | -0.01 | |
| Debt Issued | 51.04 | 0.11 | -0.31 | 0.04 | -0.20 | -2.60 | -3.41 | 15.95 | 4.30 | 0.09 | |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | |
| Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4.00 | |
| Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.16 | -1.19 | |
| Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 | |
| Cash from Financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.97 | -5.16 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Net Change in Cash | -2.13 | -0.14 | -1.17 | 2.19 | -4.99 | |
| Closing Cash Balance | 6.30 | 10.22 | 10.35 | 11.52 | 9.33 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -5.51 | 3.12 | 1.74 | 0.53 | 2.45 | 1.60 | -3.04 | -2.19 | 3.95 | -0.86 | |
| Closing Cash Balance | 10.22 | 15.73 | 12.61 | 10.88 | 10.35 | 7.89 | 6.30 | 9.33 | 11.52 | 7.57 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|---|
| Free Cash Flow | 12.95 | 12.85 | 13.94 | 12.65 | 11.95 | |
| Real Free Cash Flow | 12.43 | 12.29 | 13.44 | 12.13 | 11.49 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 1.60 | 5.99 | 3.56 | 1.69 | 4.06 | 5.27 | 2.06 | 2.55 | 3.92 | 4.41 | |
| Real Free Cash Flow | 1.47 | 5.85 | 3.42 | 1.55 | 3.94 | 5.14 | 1.94 | 2.42 | 3.80 | 4.28 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | 16.6 | 1.2 | 86.1 |
| P/S | 2.4 | 2.2 | 578 |
| P/B | 6.3 | 5.8 | 582.9 |
| P/FCF | 9.5 | 7.9 | 10581.1 |
| Market cap | $95.5 | $101.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 0 % | 47.4 % | 0 % |
| Debt to Income | 723.7 % | 90.3 % | 0 % |
| Debt to Free cash flow | 415.2 % | 23.5 % | 0 % |
| Interest expense percentage | 11.9 % | 14.3 % | 7 % |
| Current ratio | 1.3 | 1.1 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | 38 % | -3.1 % | 0 % |
| ROA | 7.3 % | 0.2 % | 0 % |
| CapEx to Revenue | 2.7 % | 2.8 % | 10.5 % |
| RaD to Revenue | 0 % | 16.7 % | 0 % |
| ROEM | 1,413,313.8 | 366697.9 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 67.6 % | 69.7 % | 77.7 % |
| Operating margin | 26.3 % | 25.8 % | 29.4 % |
| Net margin | 14.6 % | 2.4 % | 22.3 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 3.6 % | 0 % |
| Dividend payout percentage | 0 % | 5.8 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 2,041.0 mil | 2,037.1 mil |
| Employee count | 34.1 tis | 27.0 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
